Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Intellia Therapeutics (NASDAQ:NTLA) Slips on Q2 Revenue Miss Despite In-Line Loss ↗
Via Chartmill
Tickers NTLA
NETSCOUT Systems (NASDAQ:NTCT) Shares Dip Despite Q1 Beat as Full-Year Guidance Trails Consensus ↗
Via Chartmill
Tickers NTCT
MACOM (NASDAQ:MTSI) Falls Despite Strong Q4 Guidance ↗
Via Chartmill
Tickers MTSI
Lexicon Pharmaceuticals (NASDAQ:LXRX) Falls as Q2 Revenue Misses Estimates ↗
Via Chartmill
Tickers LXRX
Cheniere Energy (NYSE:LNG) Rises on Q2 Revenue Beat and Raised Full-Year Guidance ↗
Via Chartmill
Tickers LNG
Ligand Pharmaceuticals (NASDAQ:LGND) Beats Q2 EPS Estimates, Shares Flat on In-Line Revenue ↗
Via Chartmill
Tickers LGND
Lifetime Brands (NASDAQ:LCUT) Jumps on Q2 Earnings Surprise as Loss Expected Turns to Profit ↗
Via Chartmill
Tickers LCUT
Lincoln International (NYSE:LCLN) Jumps 7.6% After Blowout Q2 Earnings Beat ↗
Via Chartmill
Tickers LCLN
KVH Industries (NASDAQ:KVHI) Shares Drop 10% on Mixed Q2 Results ↗
Via Chartmill
Tickers KVHI
Koppers Holdings (NYSE:KOP) Tops Adjusted EPS Estimates in Q2 2026 ↗
Via Chartmill
Tickers KOP
Kelly Services (NASDAQ:KELYA) Posts Strong Q2 Earnings Beat but Stock Ticks Lower ↗
Via Chartmill
Topics Earnings
Tickers KELYA
Exposures Financial
Keurig Dr Pepper (NASDAQ:KDP) Tops Q2 Profit Estimates, Reaffirms Full-Year Outlook ↗
Via Chartmill
Tickers KDP
ITT Inc (NYSE:ITT) Beats Q2 Estimates and Raises Full-Year Guidance ↗
Via Chartmill
Tickers ITT
Ironwood Pharmaceuticals (NASDAQ:IRWD) Raises Full-Year Guidance on Strong LINZESS Sales Despite Q2 Miss ↗
Via Chartmill
Tickers IRWD
Iovance Biotherapeutics (NASDAQ:IOVA) Beats Q2 Estimates on Record Revenue, Shares Jump ↗
Via Chartmill
Tickers IOVA
Immunocore (NASDAQ:IMCR) Q2 Revenue Beats but EPS Misses, Shares Tumble ↗
Via Chartmill
Tickers IMCR
InflaRx (NASDAQ:IFRX) Tumbles After Q2 Results Miss Estimates ↗
Via Chartmill
Tickers IFRX
Installed Building Products (NYSE:IBP) Beats Q2 Estimates but Shares Fall on Soft Residential Housing Market ↗
Via Chartmill
Tickers IBP
Howmet Aerospace (NYSE:HWM) Beats Q2 Estimates and Raises Full-Year 2026 Guidance ↗
Via Chartmill
Tickers HWM
Green Plains (NASDAQ:GPRE) Beats Q2 EPS but Revenue Misses; Shares Dip ↗
Via Chartmill
Tickers GPRE
Gogo (NASDAQ:GOGO) Plunges on Q2 Miss and Soft 2026 Guidance ↗
Via Chartmill
Tickers GOGO
Monte Rosa Therapeutics (NASDAQ:GLUE) Beats Q2 Revenue Estimates but Posts Wider Loss ↗
Via Chartmill
Tickers GLUE
GEO Group (NYSE:GEO) Tops Q2 Earnings Estimates and Raises Full-Year Guidance ↗
Via Chartmill
Tickers GEO
FrontView REIT (NYSE:FVR) Beats EPS and Raises Outlook as Revenue Miss Fades ↗
Via Chartmill
Tickers FVR
Frontdoor (NASDAQ:FTDR) Tops Q2 Earnings Estimates and Raises Guidance ↗
Via Chartmill
Tickers FTDR
Shift4 Payments (NYSE:FOUR) Falls 10% Despite Q2 Beat ↗
Via Chartmill
Tickers FOUR
Fiserv (NASDAQ:FISV) Slumps as Q2 Miss and Lowered Guidance Disappoint ↗
Via Chartmill
Tickers FISV
Evergy (NASDAQ:EVRG) Tops Q2 Estimates, Yet Stock Stays Flat as Guidance Holds ↗
Via Chartmill
Tickers EVRG
Evolent Health (NYSE:EVH) Jumps 18% After Q2 Revenue and EPS Smash Estimates ↗
Via Chartmill
Tickers EVH
EuroDry (NASDAQ:EDRY) Advances on Q2 Earnings Beat Despite Revenue Miss ↗
Via Chartmill
Topics Earnings
Tickers EDRY
Exposures Financial
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.